194 related articles for article (PubMed ID: 30396878)
1. Clinical and Laboratory Characteristics of Hyperprolactinemia in Children and Adolescents: National Survey.
Eren E; Törel Ergür A; İşgüven ŞP; Çelebi Bitkin E; Berberoğlu M; Şıklar Z; Baş F; Yel S; Baş S; Söbü E; Bereket A; Turan S; Sağlam H; Atay Z; Ercan O; Güran T; Atabek ME; Korkmaz HA; Kılınç Uğurlu A; Akıncı A; Döğer E; Şimşek E; Akbaş ED; Abacı A; Gül Ü; Acar S; Mengen Uçaktürk E; Yıldız M; Ünal E; Tarım Ö
J Clin Res Pediatr Endocrinol; 2019 May; 11(2):149-156. PubMed ID: 30396878
[TBL] [Abstract][Full Text] [Related]
2. Hyperprolactinemia: a 12-year retrospective study at gynecologic endocrinology unit, Siriraj Hospital.
Saejong R; Dangrat C; Techatrisak K; Angsuwatthana S; Rattanachaiyanont M; Tanmahasamut P
J Med Assoc Thai; 2013 Oct; 96(10):1247-56. PubMed ID: 24350404
[TBL] [Abstract][Full Text] [Related]
3. Frequency of Macroprolactin in Hyperprolactinemia.
Sherazi NA; Baig MZ; Khan AH
J Coll Physicians Surg Pak; 2018 Feb; 28(2):93-97. PubMed ID: 29394965
[TBL] [Abstract][Full Text] [Related]
4. Detection, evaluation, and treatment of pituitary microadenomas in patients with galactorrhea and amenorrhea.
Chang RJ; Keye WR; Young JR; Wilson CB; Jaffe RB
Am J Obstet Gynecol; 1977 Jun; 128(4):356-63. PubMed ID: 559413
[TBL] [Abstract][Full Text] [Related]
5. Hyperprolactinemia: pathophysiology and management.
Verhelst J; Abs R
Treat Endocrinol; 2003; 2(1):23-32. PubMed ID: 15871552
[TBL] [Abstract][Full Text] [Related]
6. Clinical course of hyperprolactinemia in children and adolescents: a review of 21 cases.
Eren E; Yapıcı Ş; Çakır ED; Ceylan LA; Sağlam H; Tarım Ö
J Clin Res Pediatr Endocrinol; 2011; 3(2):65-9. PubMed ID: 21750634
[TBL] [Abstract][Full Text] [Related]
7. True hyperprolactinemia in men without visible pituitary adenoma.
Shimon I; Rudman Y; Manisterski Y; Gorshtein A; Masri H; Duskin-Bitan H
Endocrine; 2021 Jun; 72(3):809-813. PubMed ID: 33566310
[TBL] [Abstract][Full Text] [Related]
8. Gender differences in the prevalence, clinical features and response to cabergoline in hyperprolactinemia.
Colao A; Sarno AD; Cappabianca P; Briganti F; Pivonello R; Somma CD; Faggiano A; Biondi B; Lombardi G
Eur J Endocrinol; 2003 Mar; 148(3):325-31. PubMed ID: 12611613
[TBL] [Abstract][Full Text] [Related]
9. Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients.
Verhelst J; Abs R; Maiter D; van den Bruel A; Vandeweghe M; Velkeniers B; Mockel J; Lamberigts G; Petrossians P; Coremans P; Mahler C; Stevenaert A; Verlooy J; Raftopoulos C; Beckers A
J Clin Endocrinol Metab; 1999 Jul; 84(7):2518-22. PubMed ID: 10404830
[TBL] [Abstract][Full Text] [Related]
10. Hyperprolactinaemia and pituitary adenomas in adolescence.
Dissaneevate P; Warne GL
J Pediatr Endocrinol Metab; 1998; 11(4):531-41. PubMed ID: 9777574
[TBL] [Abstract][Full Text] [Related]
11. Galactorrhea: Rapid Evidence Review.
Bruehlman RD; Winters S; McKittrick C
Am Fam Physician; 2022 Dec; 106(6):695-700. PubMed ID: 36521467
[TBL] [Abstract][Full Text] [Related]
12. Hyperprolactinemia: etiology, diagnosis, and management.
Mah PM; Webster J
Semin Reprod Med; 2002 Nov; 20(4):365-74. PubMed ID: 12536359
[TBL] [Abstract][Full Text] [Related]
13. Epidemiological and clinical profiles of Saudi patients with hyperprolactinemia in a single tertiary care center.
Mahzari M; Alhamlan KS; Alhussaini NA; Alkathiri TA; Al Khatir AN; Alqahtani AM; Masuadi EF
Ann Saudi Med; 2022; 42(5):334-342. PubMed ID: 36252148
[TBL] [Abstract][Full Text] [Related]
14. Hyperprolactinemia: different clinical expression in childhood.
Saranac L; Zivanovic S; Radovanovic Z; Kostic G; Markovic I; Miljkovic P
Horm Res Paediatr; 2010; 73(3):187-92. PubMed ID: 20197671
[TBL] [Abstract][Full Text] [Related]
15. [Management of Hyperprolactinemia at the Hôpital du Mali].
Mariko M; Traoré B; Sow DS; Coulibaly K; Bah M; Koné A; Traoré D; Drago A; N'Diaye HD; Mariko ML; Minkailou M; Dramé A; Konaté M; Guindo A; Diallo MB; Sidibé AT
Mali Med; 2020; 35(2):26-31. PubMed ID: 37978778
[TBL] [Abstract][Full Text] [Related]
16. Guidelines for the diagnosis and treatment of hyperprolactinemia.
Biller BM; Luciano A; Crosignani PG; Molitch M; Olive D; Rebar R; Sanfilippo J; Webster J; Zacur H
J Reprod Med; 1999 Dec; 44(12 Suppl):1075-84. PubMed ID: 10649814
[TBL] [Abstract][Full Text] [Related]
17. Treatment of hyperprolactinemia: a systematic review and meta-analysis.
Wang AT; Mullan RJ; Lane MA; Hazem A; Prasad C; Gathaiya NW; Fernández-Balsells MM; Bagatto A; Coto-Yglesias F; Carey J; Elraiyah TA; Erwin PJ; Gandhi GY; Montori VM; Murad MH
Syst Rev; 2012 Jul; 1():33. PubMed ID: 22828169
[TBL] [Abstract][Full Text] [Related]
18. Hyperprolactinemia in children: clinical features and long-term results.
Catli G; Abaci A; Altincik A; Demir K; Can S; Buyukgebiz A; Bober E
J Pediatr Endocrinol Metab; 2012; 25(11-12):1123-8. PubMed ID: 23329759
[TBL] [Abstract][Full Text] [Related]
19. Lack of tumor reduction in hyperprolactinemic women with extrasellar macroadenomas treated with bromocriptine.
Boulanger CM; Mashchak CA; Chang RJ
Fertil Steril; 1985 Oct; 44(4):532-5. PubMed ID: 4054327
[TBL] [Abstract][Full Text] [Related]
20. [Hyperprolactinemia in patients with non-functioning adenoma: analysis of 85 patients treated by transsphenoidal operation].
Saitoh Y; Mori S; Arita N; Hayakawa T; Mogami H; Oku Y; Onishi T; Uozumi T
No Shinkei Geka; 1987 Nov; 15(11):1175-9. PubMed ID: 3437926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
